J&J Beats Q3 Earnings On Strong Drug Sales, Ups View
October 14, 2014 at 17:39 PM EDT
Johnson & Johnson’s third quarter sales jumped 5.1% year-over-year to $18.5 billion, beating the Zacks Consensus Estimate of $18.4 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.